Literature DB >> 10364016

A comparison of three fingerstick, whole blood antibody tests for Helicobacter pylori infection: a United States, multicenter trial.

W D Chey1, U Murthy, S Shaw, A Zawadski, J Montague, W Linscheer, L Laine.   

Abstract

OBJECTIVE: We compared three whole blood antibody tests for Helicobacter pylori (H. pylori) in a United States, multicenter trial.
METHODS: Patients referred for EGD at three medical centers were recruited. During EGD, biopsies were taken for histology and rapid urease testing (RUT). Immediately after endoscopy, patients underwent the antibody tests (FlexPack HP, Abbott Diagnostics; QuikVue, Quidel Corporation; AccuMeter, ChemTrak) using whole blood obtained by two to three fingersticks. Performance characteristics were calculated for each antibody test using the biopsy-based methods as a gold standard.
RESULTS: A total of 131 patients participated; 50 (38%) patients had histological evidence of H. pylori infection. Using histology as a gold standard, the sensitivities of FlexPack HP, QuikVue, and Accumeter were 76%, 78%, and 84%, respectively. Specificity was 79% with FlexPack HP and 90% with QuikVue and Accumeter. There were no significant differences in the performance of the three antibody tests though there was a trend toward superior performance for AccuMeter compared to FlexPack HP (p = 0.019). However, RUT proved superior to FlexPack HP using histology as a gold standard (p = 0.008). Using either concordant histology and RUT results or a positive histology or RUT to define active H. pylori infection, there was no statistically significant difference between the antibody tests.
CONCLUSIONS: There were no statistically significant differences in the performance of the three antibody tests. These tests proved only marginally sensitive in detecting patients infected with H. pylori. Clinicians should be aware of the limitations of these tests, particularly when using them as a sole means of testing for H. pylori.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364016     DOI: 10.1111/j.1572-0241.1999.1135_x.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  6 in total

Review 1.  Blood, urine, stool, breath, money, and Helicobacter pylori.

Authors:  D Vaira; N Vakil
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

2.  Validation of four Helicobacter pylori rapid blood tests in a multi-ethnic Asian population.

Authors:  Lee-Guan Lim; Khay-Guan Yeoh; Bow Ho; Seng-Gee Lim
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

3.  A novel line immunoassay based on recombinant virulence factors enables highly specific and sensitive serologic diagnosis of Helicobacter pylori infection.

Authors:  Luca Formichella; Laura Romberg; Christian Bolz; Michael Vieth; Michael Geppert; Gereon Göttner; Christina Nölting; Dirk Walter; Wolfgang Schepp; Arne Schneider; Kurt Ulm; Petra Wolf; Dirk H Busch; Erwin Soutschek; Markus Gerhard
Journal:  Clin Vaccine Immunol       Date:  2013-09-04

4.  Things We Do for No Reason™: Serum Serologic Helicobacter pylori Testing.

Authors:  Anthony A Xu; David Y Graham
Journal:  J Hosp Med       Date:  2021-11       Impact factor: 2.960

Review 5.  Non-invasive tests for the diagnosis of helicobacter pylori: state of the art.

Authors:  Stefano Kayali; Rosalia Aloe; Chiara Bonaguri; Federica Gaiani; Marco Manfredi; Gioacchino Leandro; Fabiola Fornaroli; Francesco Di Mario; Gian Luigi De' Angelis
Journal:  Acta Biomed       Date:  2018-12-17

6.  Serodiagnosis and Bacterial Genome of Helicobacter pylori Infection.

Authors:  Aina Ichihara; Hinako Ojima; Kazuyoshi Gotoh; Osamu Matsushita; Susumu Take; Hiroyuki Okada; Akari Watanabe; Kenji Yokota
Journal:  Toxins (Basel)       Date:  2021-07-05       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.